
GemVax&KAEL Co.,Ltd Acción · KR7082270000 (XKOS) — cotizaciones en tiempo real, datos de la empresa, dividendos, fundamentales y análisis de cartera con IA en MoneyPeak
Análisis impulsado por IA
Análisis fundamental
Descubre lo que realmente dicen los números — antes que el mercado
Analizar ahora
Sentimiento de noticias
¿Las noticias de hoy son una señal de compra o una alerta?
Analizar ahora
Comprar / Mantener / Vender
¿Comprar, mantener o vender? Obtén el veredicto de la IA ahora.
Analizar ahora
Evaluación de riesgos
Descubre riesgos ocultos antes de que afecten a tu cartera.
Analizar ahora
Valor justo
¿Esta acción está barata, correctamente valorada o sobrevalorada?
Analizar ahora
Latest AI Analyses of GemVax&KAEL Co.,Ltd
No Price
Closing Price XKOS 30.04.2026:
23.800,00 KRW
30.04.2026 06:30
Current Prices from GemVax&KAEL Co.,Ltd
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
KOSDAQ |
082270.KQ
|
KRW
|
30.04.2026 06:30
|
23.800,00 KRW
| - |
Invested Funds
The following funds have invested in GemVax&KAEL Co.,Ltd:
Fund | Vol. in million 76,94 | Percentage (%) 0,07 % |
Fund | Vol. in million 32,48 | Percentage (%) 0,01 % |
Fund | Vol. in million 164,41 | Percentage (%) 0,01 % |
Company Profile for GemVax&KAEL Co.,Ltd Share
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. It operates through the Environmental Pollution Control project and Bio business divisions. The Environmental Pollution Control project business division focuses on the manufacture of filters necessary for the semiconductor and display manufacturing process and the air pollution/odor prevention equipment business. The Bio business division refers to the preparation for phase 2 and 3 clinical trials at home and abroad for various indications such as Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy with GV1001, a telomerase-derived peptide-based new drug substance. The company was founded on March 10, 1998 and is headquartered in Daejeon, South Korea.
Company Data
Name GemVax&KAEL Co.,Ltd
Company GemVax&KAEL Co.,Ltd
Website
https://www.gemvax.com
Primary Exchange
KOSDAQ
ISIN KR7082270000
Asset Class Share
Market Capitalization 1.001 Mrd.
Currency KRW
Employees -
IPO Date 2005-06-24
Dividends from 'GemVax&KAEL Co.,Ltd'
| Ex-Date | Dividend per Share |
|---|---|
| 27.12.2007 | 150,00 KRW |
| 27.12.2006 | 100,00 KRW |
| 28.12.2005 | 50,00 KRW |
Ticker Symbols
| Name | Symbol |
|---|---|
| KOSDAQ | 082270.KQ |
More Shares
Investors who hold GemVax&KAEL Co.,Ltd also have the following shares in their portfolio:
